Scripps Research Translational Institute, La Jolla, California (D.P.O., E.J.T.).
Ann Intern Med. 2021 May;174(5):655-662. doi: 10.7326/M20-6976. Epub 2021 Jan 22.
Asymptomatic infection seems to be a notable feature of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen that causes coronavirus disease 2019 (COVID-19), but the prevalence is uncertain.
To estimate the proportion of persons infected with SARS-CoV-2 who never develop symptoms.
Searches of Google News, Google Scholar, medRxiv, and PubMed using the keywords , , , , , , and .
Observational, descriptive studies and reports of mass screening for SARS-CoV-2 that were either cross-sectional or longitudinal in design; were published through 17 November 2020; and involved SARS-CoV-2 nucleic acid or antibody testing of a target population, regardless of current symptomatic status, over a defined period.
The authors collaboratively extracted data on the study design, type of testing performed, number of participants, criteria for determining symptomatic status, testing results, and setting.
Sixty-one eligible studies and reports were identified, of which 43 used polymerase chain reaction (PCR) testing of nasopharyngeal swabs to detect current SARS-CoV-2 infection and 18 used antibody testing to detect current or prior infection. In the 14 studies with longitudinal data that reported information on the evolution of symptomatic status, nearly three quarters of persons who tested positive but had no symptoms at the time of testing remained asymptomatic. The highest-quality evidence comes from nationwide, representative serosurveys of England ( = 365 104) and Spain ( = 61 075), which suggest that at least one third of SARS-CoV-2 infections are asymptomatic.
For PCR-based studies, data are limited to distinguish presymptomatic from asymptomatic infection. Heterogeneity precluded formal quantitative syntheses.
Available data suggest that at least one third of SARS-CoV-2 infections are asymptomatic. Longitudinal studies suggest that nearly three quarters of persons who receive a positive PCR test result but have no symptoms at the time of testing will remain asymptomatic. Control strategies for COVID-19 should be altered, taking into account the prevalence and transmission risk of asymptomatic SARS-CoV-2 infection.
National Institutes of Health.
无症状感染似乎是严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的一个显著特征,SARS-CoV-2 是导致 2019 冠状病毒病(COVID-19)的病原体,但流行情况尚不确定。
估计感染 SARS-CoV-2 但从未出现症状的人群比例。
使用关键词“coronavirus,”“COVID-19,”“SARS-CoV-2,”“asymptomatic infection,”“seroprevalence,”“PCR,”和“antibody”,在 Google News、Google Scholar、medRxiv 和 PubMed 上进行搜索。
观察性、描述性研究以及 SARS-CoV-2 大规模筛查的报告,研究设计为横断面或纵向;通过 2020 年 11 月 17 日之前发表;并涉及 SARS-CoV-2 核酸或抗体检测,检测对象为目标人群,无论当前的症状状态如何,在定义的时间段内进行。
作者合作提取了研究设计、进行的检测类型、参与者数量、确定症状状态的标准、检测结果和研究地点等数据。
确定了 61 项符合条件的研究和报告,其中 43 项使用聚合酶链反应(PCR)检测鼻咽拭子来检测当前的 SARS-CoV-2 感染,18 项使用抗体检测来检测当前或先前的感染。在 14 项具有纵向数据的研究中,报告了症状状态演变的信息,近四分之三在检测时呈阳性但无症状的人仍然无症状。最优质的证据来自英格兰( = 365 104)和西班牙( = 61 075)全国代表性血清学调查,表明至少三分之一的 SARS-CoV-2 感染是无症状的。
对于基于 PCR 的研究,数据仅限于区分前驱期和无症状感染。异质性排除了正式的定量综合。
现有数据表明,至少三分之一的 SARS-CoV-2 感染是无症状的。纵向研究表明,近四分之三在检测时呈阳性但无症状的人将保持无症状。应改变针对 COVID-19 的控制策略,考虑无症状 SARS-CoV-2 感染的流行率和传播风险。
美国国立卫生研究院。